v3.26.1
Collaboration Revenue - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Oct. 22, 2025
May 31, 2025
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2025
May 31, 2026
Apr. 30, 2026
Apr. 01, 2026
Jun. 30, 2025
Disaggregation Of Revenue [Line Items]                    
Accrued Liability     $ 200 $ 200   $ 200        
Collaboration revenue     5,686   $ 421          
Short-term research and development contract liability     0 5,335   5,335        
Prepaid expenses and other short-term assets     1,701 1,309   1,309        
Other long-term assets     90 94   94        
Accounts receivable     5,351 5,546   5,546        
Subsequent Event                    
Disaggregation Of Revenue [Line Items]                    
Upfront payment               $ 15,000    
Milestone payment               676,500    
Milestone Payment               $ 676,500    
Ono Collaboration and Option Agreement                    
Disaggregation Of Revenue [Line Items]                    
Collaboration revenue     0   $ 400          
BI Collaboration and License Agreement                    
Disaggregation Of Revenue [Line Items]                    
Up Front Non Refundable Payment     1,900              
Upfront payment                   $ 10,100
Collaboration revenue     5,700              
Short-term research and development contract liability       5,300   5,300        
Success-based research, development and commercial milestone payments     345,000              
Accounts receivable     400 500   500        
BI Collaboration and License Agreement | Einstein                    
Disaggregation Of Revenue [Line Items]                    
Amortization of intangible assets   $ 600                
Cost of Product and Service Sold   $ 1,100 1,100              
Prepaid expenses and other short-term assets       500   500        
BI Collaboration and License Agreement | Subsequent Event                    
Disaggregation Of Revenue [Line Items]                    
Milestone payment             $ 7,500   $ 7,500  
Milestone Payment             $ 7,500   $ 7,500  
Einstein License And Service Agreement                    
Disaggregation Of Revenue [Line Items]                    
Payment for License Agreement     1,000     1,500        
ImmunoScape Collaboration and License Agreement                    
Disaggregation Of Revenue [Line Items]                    
Upfront payment     15,000              
Fair value of equity interest     3,900              
Collaboration revenue $ 5,000   0 9,500            
Option time based payment       10,000            
Additional time based payment     5,000              
Accounts receivable     $ 5,000 $ 5,000   $ 5,000        
ImmunoScape Collaboration and License Agreement | ImmunoScape Pte Ltd                    
Disaggregation Of Revenue [Line Items]                    
Percenatage of equity issued and outstanding     40.00%